StockData
MaxCyte, Inc. logo

MaxCyte, Inc. (MXCT) stock

MXCTNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/3065% below fair value
$1.17−0.01 (-0.85%)

Close on Nov 17, 2026Market cap $120.75MP/E –Yield –

MaxCyte shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

MaxCyte's shares outstanding was 107M at Jun 30, 2026. For fiscal 2025 it was 106M, up 1.5% from the year before. The highest annual figure on record is 106M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 2025106M+1.5%
FY2024Dec 31, 2024105M+1.5%
FY2023Dec 31, 2023103M+1.5%
FY2022Dec 31, 2022102M+12.2%
FY2021Dec 31, 202191M+30.5%
FY2020Dec 31, 202069M+23.2%
FY2019Dec 31, 201956M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026107M+0.4%
Q1 FY2026Mar 31, 2026107M+0.9%
Q4 FY2025Dec 31, 2025107M+1.1%
Q3 FY2025Sep 30, 2025107M+1.4%
Q2 FY2025Jun 30, 2025106M+1.7%
Q1 FY2025Mar 31, 2025106M+1.8%
Q4 FY2024Dec 31, 2024106M+1.8%
Q3 FY2024Sep 30, 2024105M+1.6%
Q2 FY2024Jun 30, 2024105M+1.5%
Q1 FY2024Mar 31, 2024104M+1.2%
Q4 FY2023Dec 31, 2023104M+1.5%
Q3 FY2023Sep 30, 2023103M+1.6%
Q2 FY2023Jun 30, 2023103M+1.6%
Q1 FY2023Mar 31, 2023103M+1.5%
Q4 FY2022Dec 31, 2022102M+1.2%
Q3 FY2022Sep 30, 2022102M+20.2%
Q2 FY2022Jun 30, 2022101M+19.7%
Q1 FY2022Mar 31, 2022101M+25.1%
Q4 FY2021Dec 31, 2021101M+30.4%
Q3 FY2021Sep 30, 202185M+9.9%
Q2 FY2021Jun 30, 202185M+28.7%
Q1 FY2021Mar 31, 202181M–
Q4 FY2020Dec 31, 202077M–
Q3 FY2020Sep 30, 202077M–
Q2 FY2020Jun 30, 202066M–

More MaxCyte figures

See a number that looks wrong?